SynthesisBMJ open2022

Cardiovascular and renal efficacy and safety of sodium-glucose cotransporter-2 inhibitors in patients without diabetes: a systematic review and meta-analysis of randomised placebo-controlled trials.

Wan-Chuan Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.